D61.81 - Pancytopenia
- Applicable to Pancytopenia
- The 2025 edition of ICD10-CM D61.81 became effective on October 1, 2024.
- This is the American ICD10-CM version of D61.81 - other international versions of ICD10 D61.81 may differ.
- D61.81 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- D61.81 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- D61.81 - Pancytopenia
- D61.81 - Pancytopenia
- D61.810 - Antineoplastic chemotherapy induced pancytopenia
- D61.811 - Other drug-induced pancytopenia
- D61.818 - Other pancytopenia
Type 1 Excludes
- pancytopenia (due to) (with) aplastic anemia (D61.9)
- pancytopenia (due to) (with) bone marrow infiltration (D61.82)
- pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
- pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
- pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
- pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
- pancytopenia (due to) (with) myeloproliferative disease (D47.1)
Type 2 Excludes
- pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
The following codes above D61.81 contain annotation back-references that may be applicable to D61.81:
Section: D60-D64 Aplastic and other anemias and other bone marrow failure syndromes
Category: D61 Other aplastic anemias and other bone marrow failure syndromes
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com